Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

A Fusi; F Blackhall; P Koh; C Dive; I Stratford; K Williams; N Bayman; L Ashcroft; T Coyne; S Falk; C Faivre-Finn

Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

A Fusi, F Blackhall, P Koh, C Dive, I Stratford, K Williams, N Bayman, L Ashcroft, T Coyne, S Falk, C Faivre-Finn

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S553-S554
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	8
Publication status	Published - Nov 2013

Keywords

MEK inhibitor
Non small cell lung cancer
Phase I trial
Thoracic radiotherapy

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Fusi, A., Blackhall, F., Koh, P., Dive, C., Stratford, I., Williams, K., Bayman, N., Ashcroft, L., Coyne, T., Falk, S., & Faivre-Finn, C. (2013). Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc). Journal of Thoracic Oncology, 8, S553-S554.

@article{1eab9d46d2ba4919b18dfab4735458a5,

title = "Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)",

keywords = "MEK inhibitor, Non small cell lung cancer, Phase I trial, Thoracic radiotherapy",

author = "A Fusi and F Blackhall and P Koh and C Dive and I Stratford and K Williams and N Bayman and L Ashcroft and T Coyne and S Falk and C Faivre-Finn",

year = "2013",

month = nov,

language = "English",

volume = "8",

pages = "S553--S554",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier BV",

}

Fusi, A, Blackhall, F, Koh, P, Dive, C, Stratford, I, Williams, K, Bayman, N, Ashcroft, L, Coyne, T, Falk, S & Faivre-Finn, C 2013, 'Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)', Journal of Thoracic Oncology, vol. 8, pp. S553-S554.

Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc). / Fusi, A; Blackhall, F; Koh, P et al.
In: Journal of Thoracic Oncology, Vol. 8, 11.2013, p. S553-S554.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

AU - Fusi, A

AU - Blackhall, F

AU - Koh, P

AU - Dive, C

AU - Stratford, I

AU - Williams, K

AU - Bayman, N

AU - Ashcroft, L

AU - Coyne, T

AU - Falk, S

AU - Faivre-Finn, C

PY - 2013/11

Y1 - 2013/11

KW - MEK inhibitor

KW - Non small cell lung cancer

KW - Phase I trial

KW - Thoracic radiotherapy

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000339624902264&DestLinkType=FullRecord&DestApp=WOS

M3 - Meeting Abstract

SN - 1556-0864

VL - 8

SP - S553-S554

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -

Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

Keywords

Research Beacons, Institutes and Platforms

UN SDGs

Other files and links

Cite this